CFM
IDXX icon

Coronation Fund Managers’s Idexx Laboratories IDXX Stock Holding History

Coronation Fund Managers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,373
Closed -$1.32M – 162
2023
Q4 		$1.32M Buy
2,373
+1,458
+159% +$684K 0.04% 140
2023
Q3 		$400K Sell
915
-1,041
-53% -$519K 0.01% 167
2023
Q2 		$982K Sell
1,956
-2,023
-51% -$969K 0.03% 164
2023
Q1 		$1.99M Sell
3,979
-1,706
-30% -$816K 0.05% 153
2022
Q4 		$2.32M Buy
+5,685
New +$2.21M 0.06% 152

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coronation Fund Managers's IDXX Position: Q1 2024 in Review

Coronation Fund Managers sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 2,373 shares — an estimated $1.32M sold.

Coronation Fund Managers first reported a position in IDXX in Q4 2022 and held it in 5 quarters. The position peaked at $2.32M in Q4 2022. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Coronation Fund Managers reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Coronation Fund Managers sold 2,373 Idexx Laboratories shares in Q1 2024, an estimated $1.32M.
  • Coronation Fund Managers first reported a position in Idexx Laboratories in Q4 2022 and held it in 5 quarters.
  • Coronation Fund Managers's Idexx Laboratories position peaked at $2.32M in Q4 2022.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Coronation Fund Managers's 13F filing for Q1 2024, filed 3 May 2024.